Juan Lü

5.5k total citations · 1 hit paper
143 papers, 4.1k citations indexed

About

Juan Lü is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Juan Lü has authored 143 papers receiving a total of 4.1k indexed citations (citations by other indexed papers that have themselves been cited), including 71 papers in Molecular Biology, 47 papers in Cancer Research and 27 papers in Oncology. Recurrent topics in Juan Lü's work include Cancer-related molecular mechanisms research (34 papers), MicroRNA in disease regulation (23 papers) and RNA modifications and cancer (19 papers). Juan Lü is often cited by papers focused on Cancer-related molecular mechanisms research (34 papers), MicroRNA in disease regulation (23 papers) and RNA modifications and cancer (19 papers). Juan Lü collaborates with scholars based in China, United States and Hong Kong. Juan Lü's co-authors include Xiong Liu, Xiangping Li, Lanjuan Li, Chen Xue, Ming‐Liang He, Ying Peng, Ganglei Li, Hsiang‐Fu Kung, Lu Wang and Junsong Wang and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Juan Lü

133 papers receiving 4.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

FTH1 Inhibits Ferroptosis Through Ferritinophagy in the 6-OHDA Model of Parkinson's Disease

2020 304 citations Juan Lü et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Juan Lü China	36	2.7k	1.9k	712	516	461	143	4.1k
Liang Zhao China	38	2.4k 0.9×	1.4k 0.7×	709 1.0×	386 0.7×	402 0.9×	166	3.7k
Jichun Zhou China	30	2.9k 1.1×	2.0k 1.1×	685 1.0×	781 1.5×	448 1.0×	79	4.5k
Yue Zhang China	39	3.1k 1.2×	1.7k 0.9×	628 0.9×	518 1.0×	359 0.8×	200	5.0k
Da Fu China	40	3.1k 1.2×	1.9k 1.0×	922 1.3×	469 0.9×	567 1.2×	165	5.0k
Fei Chen China	30	2.5k 0.9×	2.1k 1.1×	526 0.7×	316 0.6×	777 1.7×	71	3.9k
Hui Ling China	36	3.4k 1.3×	2.6k 1.4×	717 1.0×	287 0.6×	316 0.7×	125	5.0k
Li Zhao China	30	2.4k 0.9×	1.1k 0.6×	644 0.9×	298 0.6×	368 0.8×	103	3.8k
Xianghui Fu China	36	2.4k 0.9×	1.3k 0.7×	710 1.0×	474 0.9×	505 1.1×	103	4.1k
Yi Zhu China	38	1.9k 0.7×	1.0k 0.5×	778 1.1×	334 0.6×	468 1.0×	144	3.6k

Countries citing papers authored by Juan Lü

Since Specialization

Citations

This map shows the geographic impact of Juan Lü's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Juan Lü with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Juan Lü more than expected).

Fields of papers citing papers by Juan Lü

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Juan Lü. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Juan Lü. The network helps show where Juan Lü may publish in the future.

Co-authorship network of co-authors of Juan Lü

This figure shows the co-authorship network connecting the top 25 collaborators of Juan Lü. A scholar is included among the top collaborators of Juan Lü based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Juan Lü. Juan Lü is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wu, Shuai, et al.. (2025). Beyond the Plate: Unveiling the Association Between Meat Consumption and Colorectal Cancer Risk. Journal of Gastroenterology and Hepatology. 41(2). 429–442.

Lü, Juan, et al.. (2025). The Ineffectiveness of “Volume Guarantee” Mode in Live-Streaming: A Nash Bargaining Analysis with Social Network Effects and Traffic Costs. Journal of theoretical and applied electronic commerce research. 20(4). 314–314.

Jiang, Aimin, Jinxin Li, Jialin Meng, et al.. (2025). Current Application Status and Innovative Development of Surgical Robot. SHILAP Revista de lepidopterología. 1(3). 378–396.

Lü, Juan, Yuyao Yang, Shouyue Zhang, et al.. (2024). The epigenetic-modified downregulation of LOXL1 protein mediates EMT in bladder epithelial cells exposed to benzo[a]pyrene and its metabolite BPDE. International Immunopharmacology. 142(Pt B). 113232–113232. 4 indexed citations

Lü, Juan, et al.. (2023). Long non-coding RNA, FOXP4-AS1, acts as a novel biomarker of cancers. ONCOLOGIE. 25(6). 619–627. 1 indexed citations

Jiang, Aimin, Ye Zhou, Juan Lü, et al.. (2023). Copper Death Inducer, FDX1, as a Prognostic Biomarker Reshaping Tumor Immunity in Clear Cell Renal Cell Carcinoma. Cells. 12(3). 349–349. 23 indexed citations

Jiang, Aimin, Anbang Wang, Wenliang Gong, et al.. (2022). Establishment of a Prognostic Prediction and Drug Selection Model for Patients with Clear Cell Renal Cell Carcinoma by Multiomics Data Analysis. Oxidative Medicine and Cellular Longevity. 2022(1). 3617775–3617775. 14 indexed citations

Lü, Juan, Jing Guo, Jun Liu, Xiaomin Mao, & Kaijin Xu. (2022). Long Non-coding RNA MALAT1: A Key Player in Liver Diseases. Frontiers in Medicine. 8. 734643–734643. 27 indexed citations

Su, Yuanshuai, Chengzhi Li, Yu Fang, et al.. (2022). The role of LncRNA LBX2-AS1 in cancers: functions, mechanisms and potential clinical utility. Clinical & Translational Oncology. 25(2). 293–305. 9 indexed citations

10.

Wang, Haili, et al.. (2021). Alzheimer’s disease in elderly COVID-19 patients: potential mechanisms and preventive measures. Neurological Sciences. 42(12). 4913–4920. 10 indexed citations

11.

Guo, Qian, Qingchun Lu, Juan Lü, et al.. (2021). Identification of Gm15441, a Txnip antisense lncRNA, as a critical regulator in liver metabolic homeostasis. Cell & Bioscience. 11(1). 208–208. 5 indexed citations

12.

Zhang, Xiaoqian, Bin He, Ermei Chen, et al.. (2020). The aryl hydrocarbon receptor ligand ITE inhibits cell proliferation and migration and enhances sensitivity to drug‐resistance in hepatocellular carcinoma. Journal of Cellular Physiology. 236(1). 178–192. 14 indexed citations

13.

Deng, Rui, Juan Lü, Xiong Liu, et al.. (2020). <p>PD-L1 Expression is Highly Associated with Tumor-Associated Macrophage Infiltration in Nasopharyngeal Carcinoma</p>. Cancer Management and Research. Volume 12. 11585–11596. 26 indexed citations

14.

Zhang, Mengxue, et al.. (2019). The rate of fluid shear stress is a potent regulator for the differentiation of mesenchymal stem cells. Journal of Cellular Physiology. 234(9). 16312–16319. 20 indexed citations

15.

Lü, Juan, Qihui Liu, Fan Wang, et al.. (2018). Exosomal miR-9 inhibits angiogenesis by targeting MDK and regulating PDK/AKT pathway in nasopharyngeal carcinoma. Journal of Experimental & Clinical Cancer Research. 37(1). 147–147. 176 indexed citations

16.

Liu, Xiong, et al.. (2015). [A preliminary study on the assessment of swallowing function after supracricoid partial laryngectomy].. PubMed. 50(2). 95–100. 2 indexed citations

17.

Xu, Dan, Hanwen Luo, Juan Lü, et al.. (2014). Prenatal xenobiotic exposure and intrauterine hypothalamus–pituitary–adrenal axis programming alteration. Toxicology. 325. 74–84. 49 indexed citations

18.

Lü, Juan, Huanan Luo, Xiong Liu, et al.. (2013). miR-9 targets CXCR4 and functions as a potential tumor suppressor in nasopharyngeal carcinoma. Carcinogenesis. 35(3). 554–563. 86 indexed citations

19.

Lü, Juan, Ming‐Liang He, Lu Wang, et al.. (2011). MiR-26a Inhibits Cell Growth and Tumorigenesis of Nasopharyngeal Carcinoma through Repression of EZH2. Cancer Research. 71(1). 225–233. 328 indexed citations

20.

Lü, Juan, Xiangping Li, Qi Dong, Hsiang‐Fu Kung, & Ming‐Liang He. (2010). TBX2 and TBX3: The special value for anticancer drug targets. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1806(2). 268–274. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact